July 3, 2013 – FDA warns of increased risk of sprue-like enteropathy with olmesartan-containing blood pressure drugs.
July 3, 2013 – FDA warning
Announcement Date: July 3, 2013
July 3, 2013 – FDA warns of increased risk of sprue-like enteropathy with olmesartan-containing blood pressure drugs.